These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39023452)

  • 1. Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion.
    Mesnier J; Cruz-González I; Guedeney P; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Cepas-Guillén P; Salinas P; Siquier-Padilla J; Estevez-Loureiro R; Laricchia A; O'Hara G; Montalescot G; Rodés-Cabau J
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1765-1776. PubMed ID: 39023452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.
    Antúnez-Muiños P; López-Tejero S; Cepas-Guillén P; Mon-Noboa M; Ruiz-Nodar JM; Andrés-Lalaguna L; Rivero F; Córdoba-Soriano JG; Amat-Santos IJ; Caneiro-Queija B; Sánchez DM; Sánchez JJ; Mezcua FT; Blanco-Fernández F; Sánchez JS; Moreno-Ambroj C; Estévez-Loureiro R; Nombela-Franco L; Freixa-Rofastes X; Cruz-González I
    EuroIntervention; 2024 Aug; 20(16):1018-1028. PubMed ID: 39155755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
    Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.
    Freixa X; Cruz-González I; Cepas-Guillén P; Millán X; Antúnez-Muiños P; Flores-Umanzor E; Asmarats L; Regueiro A; López-Tejero S; Li CP; Sanchis L; Rodés-Cabau J; Arzamendi D
    JAMA Cardiol; 2024 Oct; 9(10):922-926. PubMed ID: 39110427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.
    Reinhardt SW; Gibson DN; Hsu JC; Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Christen T; Allocco DJ; Freeman JV
    J Am Coll Cardiol; 2024 Sep; 84(10):889-900. PubMed ID: 39197978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kook H; Kim HD; Shim J; Kim YH; Kim JS; Pak HN; Lee HJ; Choi RK; Kang WC; Shin ES; Park JW; Yu CW; Lim DS
    PLoS One; 2021; 16(1):e0244723. PubMed ID: 33411816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.
    Duthoit G; Silvain J; Marijon E; Ducrocq G; Lepillier A; Frere C; Dimby SF; Popovic B; Lellouche N; Martin-Toutain I; Spaulding C; Brochet E; Attias D; Mansourati J; Lorgis L; Klug D; Zannad N; Hauguel-Moreau M; Braik N; Deltour S; Ceccaldi A; Wang H; Hammoudi N; Brugier D; Vicaut E; Juliard JM; Montalescot G
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008481. PubMed ID: 32674675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
    J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
    Jackson LR; Jackson KP; Thomas KL
    Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of early bleeding on long-term mortality after left atrial appendage occlusion.
    Lo Russo GV; Balla AK; Alarouri HS; Liu CH; Adi MZ; Killu AM; Alkhouli M
    Heart Rhythm; 2024 Jul; ():. PubMed ID: 39032523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion.
    Della Rocca DG; Magnocavallo M; Di Biase L; Mohanty S; Trivedi C; Tarantino N; Gianni C; Lavalle C; Van Niekerk CJ; Romero J; Briceño DF; Bassiouny M; Al-Ahmad A; Burkhardt JD; Natale VN; Gallinghouse GJ; Del Prete A; Forleo GB; Sanchez J; Lakkireddy D; Horton RP; Gibson DN; Natale A
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2353-2364. PubMed ID: 34656496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience.
    Briosa E Gala A; Pope MTB; Monteiro C; Leo M; Dawkins S; Newton JD; Betts TR
    Heart Rhythm; 2021 Oct; 18(10):1724-1732. PubMed ID: 34126270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.